Hospira Methotrexate Injection USP 50 mg/2 mL vial

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

sodium chloride, Quantity: 2.6 mg/mL; methotrexate, Quantity: 25 mg/mL

Dostupné s:

Hospira Australia Pty Ltd

INN (Mezinárodní Name):

Methotrexate,sodium chloride

Léková forma:

Injection

Složení:

Excipient Ingredients: benzyl alcohol; sodium hydroxide; water for injections; hydrochloric acid

Podání:

Intraarterial, Intravenous, Intramuscular

Jednotky v balení:

5 x 2 mL vials

Třída:

Medicine Listed (Export Only)

Druh předpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikace:

Methotrexate Injection USP belongs to a group of medicines known as anti-metabolites. It is used in high doses to treat certain types of cancers, including breast cancer, Non-Hodgkin's lymphoma and leukemia. At lower doses, it may also be used to treat severe psoriasis and severe rheumatoid arthritis.

Přehled produktů:

Visual Identification: A yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 30 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stav Autorizace:

Licence status A

Datum autorizace:

2007-09-13